Next Article in Journal
Loco-Regional and Systemic Chemotherapies for Hepato-Pancreatic Tumors: Integrated Treatments
Previous Article in Journal
Predicting the Efficacy and Safety of TACTICs (Tumor Angiogenesis-Specific CAR-T Cells Impacting Cancers) Therapy for Soft Tissue Sarcoma Patients
Previous Article in Special Issue
A 3D Heterotypic Breast Cancer Model Demonstrates a Role for Mesenchymal Stem Cells in Driving a Proliferative and Invasive Phenotype
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 12
Issue 10
10.3390/cancers12102736
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Addendum to Cancers 2020, 12(5), 1325.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Addendum

Addendum: Witschen, P.M., et al. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. Cancers 2020, 12, 1325

by
Patrice M. Witschen
1,
Thomas S. Chaffee
2,
Nicholas J. Brady
3,†,
Danielle N. Huggins
2,
Todd P. Knutson
2,4,
Rebecca S. LaRue
2,4,
Sarah A. Munro
2,4,
Lyubov Tiegs
5,
James B. McCarthy
2,5,
Andrew C. Nelson
2,5,* and
Kathryn L. Schwertfeger
2,5,6,*
1
Comparative and Molecular Biosciences Graduate Program, University of Minnesota, Minneapolis, MN 55455, USA
2
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA
3
Microbiology, Immunology and Cancer Biology Graduate Program, University of Minnesota, Minneapolis, MN 55455, USA
4
University of Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN 55455, USA
5
Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA
6
Center for Immunology, University of Minnesota, Minneapolis, MN 55455, USA
*
Authors to whom correspondence should be addressed.
†
Present address: Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA.
Cancers 2020, 12(10), 2736; https://doi.org/10.3390/cancers12102736
Submission received: 27 August 2020 / Accepted: 7 September 2020 / Published: 23 September 2020
(This article belongs to the Special Issue A Special Issue on Tumor Stroma )
Versions Notes
The authors wish to make the following corrections to this paper [1].
The authors would like to acknowledge Dr. Ali Khammanivong for providing gRNA sequences and guidance during the generation of the CD44 knockout cell lines. The authors would also like to acknowledge the Burroughs Wellcome Fund and the Howard Hughes Medical Institute Medical Research Fellowship program for providing funding for Dr. Witschen.
The original “Acknowledgments” is
Acknowledgments: The authors would like to thank Douglas Yee (funded by Masonic Cancer Center (MCC) Support Grant, P30-CA077598), and other members of the University of Minnesota Breast Cancer Translational Working Group (BrCa-TWG), for assistance with the cell line and patient Nanostring gene expression experiments. The authors would also like to thank the Elsa Pardee foundation (L.Furcht, Allen-Pardee Professor).
And should be replaced with:
Acknowledgments: The authors would like to thank Douglas Yee (funded by the Masonic Cancer Center (MCC) Support Grant, P30-CA077598), and other members of the University of Minnesota Breast Cancer Translational Working Group (BrCa-TWG), for assistance with the cell line and patient Nanostring gene expression experiments. The authors would also like to thank the Elsa Pardee foundation (L.Furcht, Allen-Pardee Professor). The authors would like to acknowledge Ali Khammanivong for providing gRNA sequences and guidance during the generation of the CD44 knockout cell lines. The authors would also like to acknowledge the Burroughs Wellcome Fund and the Howard Hughes Medical Institute Medical Research Fellowship program for providing funding for Patrice M. Witschen.
The authors would like to apologize for these omissions from the original manuscript. These changes do not affect the scientific results. The manuscript will be updated, and the original will remain online on the article webpage.

Reference

  1. Witschen, P.M.; Chaffee, T.S.; Brady, N.J.; Huggins, D.N.; Knutson, T.P.; LaRue, R.S.; Munro, S.A.; Tiegs, L.; McCarthy, J.B.; Nelson, A.C.; et al. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. Cancers 2020, 12, 1325. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Witschen, P.M.; Chaffee, T.S.; Brady, N.J.; Huggins, D.N.; Knutson, T.P.; LaRue, R.S.; Munro, S.A.; Tiegs, L.; McCarthy, J.B.; Nelson, A.C.; et al. Addendum: Witschen, P.M., et al. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. Cancers 2020, 12, 1325. Cancers 2020, 12, 2736. https://doi.org/10.3390/cancers12102736

AMA Style

Witschen PM, Chaffee TS, Brady NJ, Huggins DN, Knutson TP, LaRue RS, Munro SA, Tiegs L, McCarthy JB, Nelson AC, et al. Addendum: Witschen, P.M., et al. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. Cancers 2020, 12, 1325. Cancers. 2020; 12(10):2736. https://doi.org/10.3390/cancers12102736

Chicago/Turabian Style

Witschen, Patrice M., Thomas S. Chaffee, Nicholas J. Brady, Danielle N. Huggins, Todd P. Knutson, Rebecca S. LaRue, Sarah A. Munro, Lyubov Tiegs, James B. McCarthy, Andrew C. Nelson, and et al. 2020. "Addendum: Witschen, P.M., et al. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. Cancers 2020, 12, 1325" Cancers 12, no. 10: 2736. https://doi.org/10.3390/cancers12102736

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop